Emerson Invests in Fluxa
February 25 2021 - 4:00PM
Business Wire
Software solution enables fast technology
transfer from R&D to production in life sciences market
Emerson (NYSE: EMR), a technology and industrial software
company, today announced it has made an equity investment in Fluxa,
whose Process & Knowledge Management (PKM™) software seamlessly
manages product and process specifications throughout the drug
development lifecycle. The investment will build on Emerson’s
leading life sciences capabilities and help Fluxa expand its
technology development and commercial pipeline to deliver solutions
to the market.
The emergence of COVID-19 has sparked innovation in the life
sciences manufacturing development process, as a cycle that
previously required over eight years was completed in less than 18
months through expedited research and development and automation
technologies, including those offered by Emerson. This acceleration
and its possibilities for the industry have made technology
transfer – critical to move quickly from R&D to production – a
main priority for life sciences companies.
“Emerson has continued building on our software and solutions
portfolio to accelerate automation capabilities in the life
sciences industry,” said Mark Bulanda, executive president of
Emerson’s Automation Solutions business. “As the industry’s largest
dedicated life sciences engineering and consulting organization,
this investment in an emerging and critical space will help us
continue driving progress. We are keenly focused on the evolving
needs of our customers as they advance their vital work during this
pivotal time.”
Fluxa PKM software is designed to facilitate collaboration that
improves time-to-market. It enables global sites, functions and
leaders to work together to scale pharmaceutical recipes and
execute technology transfers. Built using modern digital
technologies, it provides enterprise-grade security, scalability
and integration with other key enterprise systems.
“Emerson’s proven commitment to helping their life sciences
customers lower costs, reduce time-to-market and improve quality
makes them the ideal partner as we continue to grow at Fluxa,” said
John Miller, co-founder of Fluxa. “We are excited about how PKM is
accelerating digital transformation for our customers, and look
forward to realizing the potential of integrating with Emerson’s
execution systems,” added Suraj Pai, co-founder of Fluxa.
The investment will complement Emerson’s leadership position in
the life sciences plant floor automation market and global account
relationships. Fluxa PKM, coupled with Emerson’s DeltaV and Syncade
systems and Bio-G software, will establish a unique solution and
competitive offering to further enable customers to streamline
their operations safely and quickly.
Fluxa was founded in 2017 by Sudheesh Narayanan, Suraj Pai and
John Miller. The company is based in Glendale, Calif.
The terms of the investment were not disclosed.
About Emerson Emerson (NYSE: EMR), headquartered in St.
Louis, Missouri (USA), is a global technology and engineering
company providing innovative solutions for customers in industrial,
commercial and residential markets. Our Automation Solutions
business helps process, hybrid and discrete manufacturers maximize
production, protect personnel and the environment while optimizing
their energy and operating costs. Our Commercial & Residential
Solutions business helps ensure human comfort and health, protect
food quality and safety, advance energy efficiency and create
sustainable infrastructure. For more information visit
Emerson.com.
Forward-Looking and Cautionary Statements Statements in
this press release that are not strictly historical may be
“forward-looking” statements, which involve risks and
uncertainties, and Emerson undertakes no obligation to update any
such statements to reflect later developments. These risks and
uncertainties include the scope, duration and ultimate impact of
the COVID-19 pandemic as well as economic and currency conditions,
market demand, including related to the pandemic and oil and gas
price declines and volatility, pricing, protection of intellectual
property, cybersecurity, tariffs, competitive and technological
factors, among others, as set forth in the Company's most recent
Annual Report on Form 10-K and subsequent reports filed with the
SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210225006174/en/
Investor Contact: Pete Lilly (314) 553-2217 Media Contact:
Ashley Wiehle (618) 322-7472
Emerson Electric (NYSE:EMR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Emerson Electric (NYSE:EMR)
Historical Stock Chart
From Sep 2023 to Sep 2024